IRIS Accounts Production v24.1.9.2 04626962 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh046269622023-01-31046269622024-01-31046269622023-02-012024-01-31046269622022-01-31046269622022-02-012023-01-31046269622023-01-3104626962ns15:EnglandWales2023-02-012024-01-3104626962ns14:PoundSterling2023-02-012024-01-3104626962ns10:Director12023-02-012024-01-3104626962ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3104626962ns10:SmallEntities2023-02-012024-01-3104626962ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3104626962ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3104626962ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3104626962ns10:FullAccounts2023-02-012024-01-310462696212023-02-012024-01-3104626962ns10:Director22023-02-012024-01-3104626962ns10:RegisteredOffice2023-02-012024-01-3104626962ns5:CurrentFinancialInstruments2024-01-3104626962ns5:CurrentFinancialInstruments2023-01-3104626962ns5:Non-currentFinancialInstruments2024-01-3104626962ns5:Non-currentFinancialInstruments2023-01-3104626962ns5:ShareCapital2024-01-3104626962ns5:ShareCapital2023-01-3104626962ns5:RetainedEarningsAccumulatedLosses2024-01-3104626962ns5:RetainedEarningsAccumulatedLosses2023-01-3104626962ns5:NetGoodwill2023-02-012024-01-3104626962ns5:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3104626962ns5:NetGoodwill2023-01-3104626962ns5:NetGoodwill2024-01-3104626962ns5:NetGoodwill2023-01-3104626962ns5:LandBuildings2023-01-3104626962ns5:PlantMachinery2023-01-3104626962ns5:LandBuildings2023-02-012024-01-3104626962ns5:PlantMachinery2023-02-012024-01-3104626962ns5:LandBuildings2024-01-3104626962ns5:PlantMachinery2024-01-3104626962ns5:LandBuildings2023-01-3104626962ns5:PlantMachinery2023-01-3104626962ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3104626962ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-31
REGISTERED NUMBER: 04626962 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

B D Healthcare Limited

B D Healthcare Limited (Registered number: 04626962)

Contents of the Financial Statements
for the Year Ended 31 January 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


B D Healthcare Limited

Company Information
for the Year Ended 31 January 2024







DIRECTORS: Mrs Baldev Kaur
Mr Bhapinder Singh Bains





REGISTERED OFFICE: 196 Causeway Green Road
Oldbury
West Midlands
B68 8LS





REGISTERED NUMBER: 04626962 (England and Wales)





ACCOUNTANTS: Dhillon Accountants Limited
Chartered Accountants
Office 1
21 Hatherton Street
Walsall
WS4 2LA

B D Healthcare Limited (Registered number: 04626962)

Balance Sheet
31 January 2024

31.1.24 31.1.23
Notes £    £   
FIXED ASSETS
Intangible assets 4 881,692 102,479
Tangible assets 5 345,151 330,510
1,226,843 432,989

CURRENT ASSETS
Stocks 250,000 170,000
Debtors 6 2,221,618 1,194,083
Prepayments and accrued income 17,975 7,191
Cash at bank and in hand 281,863 586,526
2,771,456 1,957,800
CREDITORS
Amounts falling due within one year 7 (1,176,033 ) (583,017 )
NET CURRENT ASSETS 1,595,423 1,374,783
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,822,266

1,807,772

CREDITORS
Amounts falling due after more than
one year

8

(891,068

)

(71,398

)

PROVISIONS FOR LIABILITIES (7,214 ) (5,969 )
NET ASSETS 1,923,984 1,730,405

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,923,884 1,730,305
SHAREHOLDERS' FUNDS 1,923,984 1,730,405

B D Healthcare Limited (Registered number: 04626962)

Balance Sheet - continued
31 January 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 October 2024 and were signed on its behalf by:





Mrs Baldev Kaur - Director


B D Healthcare Limited (Registered number: 04626962)

Notes to the Financial Statements
for the Year Ended 31 January 2024


1. STATUTORY INFORMATION

B D Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Goodwill
Intangible fixed assets are measured at cost less accumulative amortisaion and any accumulative impairment losses. It is amortised to profit and loss account over 15 years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Freehold2% straight line basis
Plant & Machinery25% reducing basis


Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.


B D Healthcare Limited (Registered number: 04626962)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024


2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 29 (2023 - 20 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 February 2023 676,768
Additions 828,430
At 31 January 2024 1,505,198
AMORTISATION
At 1 February 2023 574,289
Charge for year 49,217
At 31 January 2024 623,506
NET BOOK VALUE
At 31 January 2024 881,692
At 31 January 2023 102,479

B D Healthcare Limited (Registered number: 04626962)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024


5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 February 2023 407,911 120,186 528,097
Additions 1,200 35,289 36,489
Disposals - (749 ) (749 )
At 31 January 2024 409,111 154,726 563,837
DEPRECIATION
At 1 February 2023 108,818 88,769 197,587
Charge for year 8,165 12,965 21,130
Eliminated on disposal - (31 ) (31 )
At 31 January 2024 116,983 101,703 218,686
NET BOOK VALUE
At 31 January 2024 292,128 53,023 345,151
At 31 January 2023 299,093 31,417 330,510

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade debtors 401,010 295,542
Other debtors 1,820,608 898,541
2,221,618 1,194,083

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Bank loans and overdrafts 123,417 27,148
Trade creditors 589,895 456,070
Taxation and social security 118,753 80,459
Other creditors 343,968 19,340
1,176,033 583,017

B D Healthcare Limited (Registered number: 04626962)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.1.24 31.1.23
£    £   
Bank loans 891,068 71,398

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 891,068 71,398

9. ULTIMATE CONTROLLING PARTY

The company's ultimate controlling party is Mrs Baldev Kaur by virtue of her ownership of the 100% issued share capital in the company.